{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,22]],"date-time":"2025-02-22T00:43:19Z","timestamp":1740184999549,"version":"3.37.3"},"reference-count":12,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2022,4,26]],"date-time":"2022-04-26T00:00:00Z","timestamp":1650931200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,4,26]],"date-time":"2022-04-26T00:00:00Z","timestamp":1650931200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100005296","name":"Universit\u00e4tsklinikum Regensburg","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100005296","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Dermatologie"],"published-print":{"date-parts":[[2022,11]]},"abstract":"<jats:title>Zusammenfassung<\/jats:title><jats:p>Das Pyoderma gangraenosum (PG) wird den neutrophilen Dermatosen zugeordnet und pr\u00e4sentiert sich klinisch in Form von schmerzhaften Ulzerationen mit einem h\u00e4ufig livid-erythemat\u00f6s unterminierten Randsaum. Die Behandlung mit immunsuppressiven Medikamenten ist oft langwierig. \u00dcber die Entstehung von malignen Tumoren in einem Pyoderma gangraenosum ist bisher in der Literatur nicht berichtet worden.<\/jats:p>","DOI":"10.1007\/s00105-022-04995-6","type":"journal-article","created":{"date-parts":[[2022,4,26]],"date-time":"2022-04-26T15:09:31Z","timestamp":1650985771000},"page":"880-883","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Entwicklung eines spindelzelligen Plattenepithelkarzinoms auf dem Boden eines lang bestehenden Pyoderma gangraenosum","Development of spindle cell squamous cell carcinoma within a\u00a0longstanding pyoderma gangrenosum"],"prefix":"10.1007","volume":"73","author":[{"given":"Konstantin","family":"Drexler","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark","family":"Berneburg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sigrid","family":"Karrer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,4,26]]},"reference":[{"key":"4995_CR1","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1007\/s40257-017-0251-7","volume":"18","author":"A Alavi","year":"2017","unstructured":"Alavi\u00a0A, French\u00a0LE, Davis\u00a0MD, Brassard\u00a0A, Kirsner\u00a0RS (2017) Pyoderma gangrenosum: an update on pathophysiology, diagnosis and treatment. Am J Clin Dermatol 18:355\u2013372","journal-title":"Am J Clin Dermatol"},{"key":"4995_CR2","volume-title":"S1-Leitlinie Pyoderma gangrenosum","author":"AWMF","year":"2020","unstructured":"AWMF (2020) S1-Leitlinie Pyoderma gangrenosum"},{"key":"4995_CR3","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1093\/jbcr\/iraa196","volume":"42","author":"C Burusapat","year":"2021","unstructured":"Burusapat\u00a0C, Wanichjaroen\u00a0N, Wongprakob\u00a0N, Satayasoontorn\u00a0K (2021) Characteristics of Marjolin\u2019s ulcers in 21st century: a retrospective study, systematic review, and surgical guideline recommendation. J\u00a0Burn Care Res 42:152\u2013166","journal-title":"J Burn Care Res"},{"issue":"2","key":"4995_CR4","doi-asserted-by":"publisher","first-page":"7","DOI":"10.5070\/D37ZF8466K","volume":"19","author":"V Cocchetto","year":"2013","unstructured":"Cocchetto\u00a0V, Magrin\u00a0P, de Paula\u00a0RA, Aid\u00e9\u00a0M, Razo\u00a0LM, Pantale\u00e3o\u00a0L (2013) Squamous cell carcinoma in chronic wound: Marjolin ulcer. Dermatol Online J 19(2):7","journal-title":"Dermatol. Online J."},{"key":"4995_CR5","doi-asserted-by":"publisher","first-page":"224","DOI":"10.7861\/clinmedicine.19-3-224","volume":"19","author":"C George","year":"2019","unstructured":"George\u00a0C, Deroide\u00a0F, Rustin\u00a0M (2019) Pyoderma gangrenosum\u2014a\u00a0guide to diagnosis and management. Clin Med 19:224\u2013228","journal-title":"Clin Med"},{"key":"4995_CR6","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.jid.2020.04.019","volume":"141","author":"C Haag","year":"2021","unstructured":"Haag\u00a0C, Hansen\u00a0T, Hajar\u00a0T, Latour\u00a0E, Keller\u00a0J, Shinkai\u00a0K, Ortega-Loayza\u00a0AG (2021) Comparison of three diagnostic frameworks for pyoderma gangrenosum. J\u00a0Invest Dermatol 141:59\u201363","journal-title":"J Invest Dermatol"},{"key":"4995_CR7","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1111\/bjd.16401","volume":"180","author":"F Jockenh\u00f6fer","year":"2019","unstructured":"Jockenh\u00f6fer\u00a0F, Wollina\u00a0U, Salva\u00a0KA, Benson\u00a0S, Dissemond\u00a0J (2019) The PARACELSUS score: a\u00a0novel diagnostic tool for pyoderma gangrenosum. Br J Dermatol 180:615\u2013620","journal-title":"Br J Dermatol"},{"key":"4995_CR8","unstructured":"Leitlinienprogramm Onkologie (Deutsche Krebsgesellschaft, Deutsche Krebshilfe, AWMF) (2020) S3-Leitlinie Aktinische Keratose und Plattenepithelkarzinom der Haut. https:\/\/www.leitlinienprogrammonkologie.de\/leitlinien\/aktinische-keratosen-und-plattenepithelkarzinom-der-haut\/. Zugegriffen: 21. M\u00e4rz 2022 (Langversion 1.1, 2020, AWMF Registernummer: 032\/022OL)"},{"key":"4995_CR9","doi-asserted-by":"publisher","first-page":"e13074","DOI":"10.1111\/dth.13074","volume":"32","author":"V Ravi","year":"2019","unstructured":"Ravi\u00a0V, Maloney\u00a0NJ, Worswick\u00a0S (2019) Neutrophilic dermatoses as adverse effects of checkpoint inhibitors: a review. Dermatol Ther 32:e13074","journal-title":"Dermatol Ther"},{"key":"4995_CR10","first-page":"215","volume":"27","author":"M Sadegh Fazeli","year":"2013","unstructured":"Sadegh Fazeli\u00a0M, Lebaschi\u00a0AH, Hajirostam\u00a0M, Keramati\u00a0MR (2013) Marjolin\u2019s ulcer: clinical and pathologic features of 83\u00a0cases and review of literature. Med J Islam Republic Iran 27:215\u2013224","journal-title":"Med J Islam Republic Iran"},{"key":"4995_CR11","first-page":"E1","volume":"32","author":"D Semeni\u010d","year":"2020","unstructured":"Semeni\u010d\u00a0D, Bukovec\u00a0P (2020) Advanced treatment options of pyoderma gangrenosum ulcers. Wounds 32:E1\u2013E5","journal-title":"Wounds"},{"key":"4995_CR12","volume-title":"Marjolin ulcer","author":"M Shah","year":"2021","unstructured":"Shah\u00a0M, Crane\u00a0JS (2021) Marjolin ulcer. StatPearls, Treasure Island (FL)"}],"container-title":["Die Dermatologie"],"original-title":[],"language":"de","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00105-022-04995-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00105-022-04995-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00105-022-04995-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,24]],"date-time":"2022-10-24T08:05:03Z","timestamp":1666598703000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00105-022-04995-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,26]]},"references-count":12,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2022,11]]}},"alternative-id":["4995"],"URL":"https:\/\/doi.org\/10.1007\/s00105-022-04995-6","relation":{},"ISSN":["2731-7005","2731-7013"],"issn-type":[{"type":"print","value":"2731-7005"},{"type":"electronic","value":"2731-7013"}],"subject":[],"published":{"date-parts":[[2022,4,26]]},"assertion":[{"value":"30 March 2022","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 April 2022","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"K.\u00a0Drexler, M.\u00a0Berneburg und S.\u00a0Karrer geben an, dass kein Interessenkonflikt besteht.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"F\u00fcr diesen Beitrag wurden von den Autoren keine Studien an Menschen oder Tieren durchgef\u00fchrt. F\u00fcr die aufgef\u00fchrten Studien gelten die jeweils dort angegebenen ethischen Richtlinien. F\u00fcr Bildmaterial oder anderweitige Angaben innerhalb des Manuskripts, \u00fcber die Patienten zu identifizieren sind, liegt von ihnen und\/oder ihren gesetzlichen Vertretern eine schriftliche Einwilligung vor.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}}]}}